Bliss GVS Pharma Limited · NSE: BLISSGVS · BSE: 506197
Bliss GVS Pharma
Quarterly results as filed with BSE. Latest: Q1 FY27 (Apr–Jun 2026), filed 12 Aug 2026.
Q1 FY27 · Consolidated
Revenue
285.58₹ Cr
+37.6% vs year ago
Net profit
51.37₹ Cr
+15.8% vs year ago
EPS, basic
4.73₹
+15.9% vs year ago
Net margin
18.0%
−3.4 pts vs year ago
Quarter by quarter
| Quarter | Revenue | YoY | Net profit | YoY | EPS (₹) | Filed |
|---|---|---|---|---|---|---|
| Q1 FY27Apr–Jun 2026 | 285.58 | +37.6% | 51.37 | +15.8% | 4.73 | 12 Aug 2026 |
| Q4 FY26Jan–Mar 2026 | 256.99 | +29.8% | 37.00 | +122.2% | 3.37 | 12 May 2026 |
| Q3 FY26Oct–Dec 2025 | 218.25 | +3.7% | 24.78 | −4.0% | 2.20 | 10 Feb 2026 |
| Q2 FY26Jul–Sep 2025 | 244.40 | +12.3% | 28.59 | +11.3% | 2.58 | 06 Nov 2025 |
| Q1 FY26Apr–Jun 2025 | 207.47 | +13.0% | 44.36 | +100.7% | 4.08 | 29 Jul 2025 |
| Q4 FY25Jan–Mar 2025 | 197.99 | −0.1% | 16.65 | Turned profit | 1.47 | 12 May 2025 |
| Q3 FY25Oct–Dec 2024 | 210.42 | +4.8% | 25.80 | −11.2% | 2.27 | 29 Jan 2025 |
| Q2 FY25Jul–Sep 2024 | 217.68 | +2.7% | 25.69 | −40.3% | 2.31 | 08 Nov 2024 |
| Q1 FY25Apr–Jun 2024 | 183.64 | +15.1% | 22.11 | +53.8% | 1.97 | 20 Aug 2024 |
| Q4 FY24Jan–Mar 2024 | 198.13 | +7.2% | (4.91) | Turned loss | (0.88) | 09 May 2024 |
| Q3 FY24Oct–Dec 2023 | 200.72 | −2.4% | 29.07 | −2.4% | 2.64 | 02 Feb 2024 |
| Q2 FY24Jul–Sep 2023 | 211.88 | +22.9% | 43.04 | +169.0% | 4.06 | 17 Nov 2023 |
| Q1 FY24Apr–Jun 2023 | 159.52 | −15.4% | 14.37 | −47.7% | 1.41 | 01 Aug 2023 |
| Q4 FY23Jan–Mar 2023 | 184.78 | +10.6% | 3.46 | −85.2% | 0.34 | 18 May 2023 |
| Q3 FY23Oct–Dec 2022 | 205.72 | −4.9% | 29.79 | Turned profit | 2.68 | 30 Jan 2023 |
| Q2 FY23Jul–Sep 2022 | 172.43 | −12.0% | 16.00 | −27.5% | 1.33 | 21 Nov 2022 |
| Q1 FY23Apr–Jun 2022 | 188.66 | +12.2% | 27.48 | +5.2% | 2.48 | 16 Aug 2022 |
| Q4 FY22Jan–Mar 2022 | 167.06 | +26.5% | 23.47 | +187.8% | 1.90 | 02 May 2022 |
| Q3 FY22Oct–Dec 2021 | 216.26 | +31.8% | (48.53) | Turned loss | (4.83) | 31 Jan 2022 |
| Q2 FY22Jul–Sep 2021 | 195.99 | +29.3% | 22.06 | +2.1% | 2.05 | 30 Oct 2021 |
| Q1 FY22Apr–Jun 2021 | 168.15 | +29.8% | 26.13 | +56.9% | 2.35 | 31 Jul 2021 |
| Q4 FY21Jan–Mar 2021 | 132.05 | +10.2% | 8.15 | +46.3% | 0.61 | 13 May 2021 |
| Q3 FY21Oct–Dec 2020 | 164.06 | +11.0% | 27.56 | +8.3% | 2.48 | 22 Jan 2021 |
| Q2 FY21Jul–Sep 2020 | 151.54 | −27.9% | 21.61 | −30.0% | 1.99 | 22 Oct 2020 |
| Q1 FY21Apr–Jun 2020 | 129.55 | −38.8% | 16.65 | −50.1% | 1.57 | 21 Aug 2020 |
| Q4 FY20Jan–Mar 2020 | 119.80 | −50.9% | 5.57 | −70.3% | 0.85 | 17 Jun 2020 |
| Q3 FY20Oct–Dec 2019 | 147.85 | −32.9% | 25.45 | −6.5% | 2.30 | 13 Feb 2020 |
| Q2 FY20Jul–Sep 2019 | 210.12 | −8.0% | 30.86 | −25.9% | 3.00 | 13 Nov 2019 |
| Q1 FY20Apr–Jun 2019 | 211.53 | +3.0% | 33.37 | −14.4% | 3.28 | 13 Aug 2019 |
| Q4 FY19Jan–Mar 2019 | 244.05 | — | 18.79 | — | 1.76 | 21 May 2019 |
| Q3 FY19Oct–Dec 2018 | 220.43 | — | 27.23 | — | 2.50 | 31 Jan 2019 |
| Q2 FY19Jul–Sep 2018 | 228.43 | — | 41.67 | — | 4.02 | 06 Nov 2018 |
| Q1 FY19Apr–Jun 2018 | 205.33 | — | 38.98 | — | 3.72 | 13 Aug 2018 |
Standalone results
| Quarter | Revenue | YoY | Net profit | YoY | EPS (₹) | Filed |
|---|---|---|---|---|---|---|
| Q1 FY27Apr–Jun 2026 | 221.59 | +35.6% | 38.62 | +83.4% | 3.65 | 12 Aug 2026 |
| Q4 FY26Jan–Mar 2026 | 211.54 | +35.6% | 32.42 | +183.1% | 3.06 | 12 May 2026 |
| Q3 FY26Oct–Dec 2025 | 164.68 | −8.3% | 18.61 | −11.6% | 1.76 | 10 Feb 2026 |
| Q2 FY26Jul–Sep 2025 | 190.23 | +4.1% | 24.79 | +45.5% | 2.35 | 06 Nov 2025 |
| Q1 FY26Apr–Jun 2025 | 163.36 | +9.7% | 21.05 | +8.4% | 2.00 | 29 Jul 2025 |
| Q4 FY25Jan–Mar 2025 | 156.00 | −4.8% | 11.45 | Turned profit | 1.08 | 12 May 2025 |
| Q3 FY25Oct–Dec 2024 | 179.59 | +11.3% | 21.05 | +1.6% | 2.00 | 29 Jan 2025 |
| Q2 FY25Jul–Sep 2024 | 182.65 | +6.6% | 17.04 | −49.7% | 1.63 | 08 Nov 2024 |
| Q1 FY25Apr–Jun 2024 | 148.96 | +36.7% | 19.42 | +159.1% | 1.85 | 20 Aug 2024 |
| Q4 FY24Jan–Mar 2024 | 163.82 | +14.2% | (11.46) | Turned loss | (1.11) | 09 May 2024 |
| Q3 FY24Oct–Dec 2023 | 161.33 | −4.4% | 20.72 | −29.2% | 1.99 | 02 Feb 2024 |
| Q2 FY24Jul–Sep 2023 | 171.32 | +23.4% | 33.89 | +33.2% | 3.25 | 17 Nov 2023 |
| Q1 FY24Apr–Jun 2023 | 108.99 | −26.0% | 7.50 | −69.6% | 0.72 | 01 Aug 2023 |
| Q4 FY23Jan–Mar 2023 | 143.42 | +3.7% | 6.11 | −35.5% | 0.60 | 18 May 2023 |
| Q3 FY23Oct–Dec 2022 | 168.79 | −11.4% | 29.28 | +7.8% | 2.81 | 30 Jan 2023 |
| Q2 FY23Jul–Sep 2022 | 138.85 | −20.4% | 25.45 | +2.9% | 2.45 | 21 Nov 2022 |
| Q1 FY23Apr–Jun 2022 | 147.28 | +10.7% | 24.65 | +13.8% | 2.38 | 16 Aug 2022 |
| Q4 FY22Jan–Mar 2022 | 138.30 | +31.4% | 9.47 | +3.4% | 1.85 | 02 May 2022 |
| Q3 FY22Oct–Dec 2021 | 190.60 | +49.6% | 27.17 | +21.0% | 2.62 | 31 Jan 2022 |
| Q2 FY22Jul–Sep 2021 | 174.43 | +46.8% | 24.73 | +31.6% | 2.39 | 30 Oct 2021 |
| Q1 FY22Apr–Jun 2021 | 133.03 | +16.7% | 21.66 | +26.7% | 2.10 | 31 Jul 2021 |
| Q4 FY21Jan–Mar 2021 | 105.23 | +7.4% | 9.16 | −44.2% | 0.89 | 13 May 2021 |
| Q3 FY21Oct–Dec 2020 | 127.44 | +2.1% | 22.46 | −4.7% | 2.18 | 22 Jan 2021 |
| Q2 FY21Jul–Sep 2020 | 118.83 | +14.2% | 18.79 | −33.9% | 1.82 | 22 Oct 2020 |
| Q1 FY21Apr–Jun 2020 | 114.02 | −1.0% | 17.10 | −28.5% | 1.66 | 21 Aug 2020 |
| Q4 FY20Jan–Mar 2020 | 97.97 | −7.7% | 16.42 | +253.9% | 1.59 | 17 Jun 2020 |
| Q3 FY20Oct–Dec 2019 | 124.82 | +30.5% | 23.56 | +101.3% | 2.28 | 13 Feb 2020 |
| Q2 FY20Jul–Sep 2019 | 104.00 | −13.3% | 28.44 | −8.4% | 2.76 | 13 Nov 2019 |
| Q1 FY20Apr–Jun 2019 | 115.16 | +9.8% | 23.92 | −11.6% | 2.32 | 13 Aug 2019 |
| Q4 FY19Jan–Mar 2019 | 106.14 | — | 4.64 | — | 0.45 | 21 May 2019 |
| Q3 FY19Oct–Dec 2018 | 95.63 | — | 11.70 | — | 1.13 | 31 Jan 2019 |
| Q2 FY19Jul–Sep 2018 | 119.97 | — | 31.05 | — | 3.01 | 06 Nov 2018 |
| Q1 FY19Apr–Jun 2018 | 104.84 | — | 27.05 | — | 2.62 | 13 Aug 2018 |
66 filings on record for this company.